Skip to main content

Table 2 CMR findings between control, RCM (DM−) group and RCM (DM+) group

From: Effects of diabetes mellitus on left ventricular function and deformation in patients with restrictive cardiomyopathies: a 3.0T CMR feature tracking study

 

Control subjects (n = 66)

RCM (DM−) (n = 136)

RCM (DM+) (n = 46)

LVEDVi, ml/m2

70.96(62.63,80.16)

76.93(67.08,88.48)*

76.26(65.96,84.89)*

LVESVi, ml/m2

23.96(19.91,28.49)

36.34(29.21,46.64)*

36.79(29.98,53.47)*

LVSVi, ml/m2

47.68(40.86,53.31)

38.70(30.41,48.22)*

32.20(24.81,42.04)*,§

LVEF, %

65.47(62.57,70.24)

51.28(42.39,60.98)*

44.63(32.19,59.37)*,§

LVMI, g/m2

40.80(35.95,46.35)

71.01(56.42,88.56)*

63.29(50.88,88.59)*

LVGFI

50.89(47.76,55.72)

31.22(23.29,40.89)*

26.07(20.37,35.71)*,§

LVMVR

0.57(0.50,0.66)

0.91(0.74,1.15)*

0.83(0.68,1.14)*

LV GPS, %

 Radial

36.37(32.67,41.48)

14.69(10.18,21.26)*

9.72(7.50,19.31)*,§

 Circumferential

− 20.59(− 22.67,− 19.01)

− 11.45(− 15.69,− 9.02)*

− 10.35(− 14.61,− 7.06)*,§

 Longitudinal

− 15.35(− 17.14,− 12.73)

− 6.43(− 8.19,− 4.49)*

− 4.93(− 6.89,− 2.92)*,§

LV PSSR (1/s)

 Radial

2.10(1.79,2.57)

1.04(0.67,1.59)*

0.95(0.68,1.59)*

 Circumferential

− 1.02(− 1.16,− 0.93)

− 0.83(− 1.10,− 0.61)*

− 0.78(− 1.02,− 0.57)*

 Longitudinal

− 0.79(− 0.93,− 0.69)

− 0.51(− 0.73,− 0.36)*

− 0.46(− 0.71,− 0.31)*

LV PDSR (1/s)

 Radial

− 2.79(− 3.20,− 2.24)

− 1.07(− 1.77,− 0.79)*

− 0.97(− 1.40,− 0.61)*

 Circumferential

1.34(1.21,1.52)

0.84(0.65,1.09)*

0.85(0.59,1.04)*

 Longitudinal

0.98(0.77,1.11)

0.53(0.42,0.69)*

0.44(0.35,0.50)*,§

LGE pattern, n

 None/focal patchy/global

–

31/40/65

14/11/21

  1. Data are presented as median (25th, 75th percentile)
  2. LVEDVi left ventricular end diastolic volume index, LVESVi left ventricular end systolic volume index, LVSVi left ventricular stroke volume index, LVEF left ventricular ejection fraction, LVMI left ventricular mass index, LVGFI left ventricular global function index, RCM restrictive cardiomyopathy, GPS global peak strain, PSSR peak systolic strain rate, PDSR peak diastolic strain rate, LGE late gadolinium enhancement
  3. *p < 0.05 versus control group (Bonferroni’s)
  4. §p < 0.05 versus RCM(DM-) group (Bonferroni’s)